Schrödinger, Inc. (SDGR)
Market Closed
24 Feb, 20:00
$
11. 29
+0.07
+0.65%
After Hours
$
+0.21 +1.83% 11. 50
849.35M Market Cap
- P/E Ratio
- Div Yield
1,392,008 Volume
- Eps
$ 11.22
Previous Close Day Range
11.16 11.52
Year Range
11.15 27.63
Want to track SDGR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SDGR earnings report is expected in 1 days (25 Feb 2026)
Earnings Preview: Schrodinger, Inc. (SDGR) Q2 Earnings Expected to Decline
Schrodinger (SDGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks | 1 year ago
Schrodinger: Buy The Drug-Discovery Platform And Get The Pipeline Nearly For Free
Schrödinger is a hybrid biopharma company specializing in physics-based computational chemistry and traditional drug development. The company aims to utilize computational methods to create better drug candidates and improve strategic decision-making in clinical trials. Schrödinger has attracted substantial investment from strategic partnerships and has a diverse pipeline of drug candidates in clinical development.
Seekingalpha | 1 year ago
1 Growth Stock That Could Dominate AI's Next Breakthrough
Highlights from analysis from 24/7 Wall Street Analysts Eric Bleeker and Austin Smith can be found below.
247wallst | 1 year ago
